Ferroptosis-associated microRNAs: Systematic review

Maria Del Carmen Candia Plata1, Juan Manuel Martínez Soto2, Jeanette Guadalupe Arredondo Damián3

  • 1Department of Medicine and Health Sciences, University of Sonora, Hermosillo, Sonora, México. carmen.candia@unison.mx.

Insights

MicroRNAs (miRNAs) are key regulators of ferroptosis, an iron-dependent cell death process. This review details how 107 miRNAs influence ferroptosis in diseases like cancer and degenerative conditions, offering potential biomarkers and therapeutic targets.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Ferroptosis is an iron-dependent cell death pathway involving lipid peroxidation.
  • MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are implicated in disease pathogenesis.
  • Dysregulation of ferroptosis is linked to various diseases, including cancers and degenerative conditions.

Purpose of the Study:

  • To systematically review and synthesize current knowledge on miRNAs involved in ferroptosis.
  • To identify specific miRNAs that inhibit or induce ferroptosis in different disease contexts.
  • To explore the potential of miRNAs as diagnostic biomarkers and therapeutic targets for ferroptosis-related disorders.

Main Methods:

  • Systematic literature search of EMBL-EBI, PubMed, Scopus, and Web of Science databases.
  • Inclusion of studies published up to October 31, 2022.
  • Analysis of 127 articles identifying 107 distinct miRNAs influencing ferroptosis.

Main Results:

  • Identified 107 distinct miRNAs that modulate ferroptosis.
  • Highlighted miRNAs acting as ferroptosis inhibitors or inducers in cancers (lung, breast, colorectal) and degenerative diseases (acute renal failure, diabetic retinopathy).
  • Detailed molecular mechanisms involving miRNA targeting of genes in iron metabolism, lipid peroxidation, and antioxidant defense.

Conclusions:

  • miRNAs are crucial regulators of ferroptosis across diverse diseases.
  • Specific miRNAs show potential as diagnostic biomarkers for ferroptosis-related conditions.
  • miRNAs represent promising therapeutic targets for novel disease management strategies.